S100A11 and Hepatic fibrosis: A reduction in injury and inflammation can lead to a reduction in liver fibrosis; however, we cannot exclude a direct effect of hepatocyte-derived S100A11-enriched EVs on hepatic stellate cells, as our studies with recombinant S100A11 protein and LX-2 cells demonstrated upregulation of fibrogenic genes.